Bumetanide Injection — FDA Drug Shortage

Current — Mullan Pharmaceutical Inc.

The FDA lists a drug shortage record for Bumetanide Injection (injection) from Mullan Pharmaceutical Inc. with status Current. The shortage was first posted on 12/13/2017.

Shortage Details

Status
Current
Company
Mullan Pharmaceutical Inc.
Package NDC
83301-0081-2
Dosage Form
Injection
Presentation
Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)
Initial Posting
12/13/2017
Revised Date